Company
Fulcrum Therapeutics Inc Is Forecast To Drop -74.42% To Hit Consensus Price Target
In the last trading session, 1.02 million Fulcrum Therapeutics Inc (NASDAQ:FULC) shares changed hands as the company’s beta touched 2.39. With the company’s per share